These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 204732

  • 21. Detection of Epstein-Barr virus in biopsied malignant lymphoma cell and its continuous culture.
    Suzuki T, Oboshi S, Ishihara N, Emura I, Ohnishi Y, Sairenji T, Hinuma Y.
    Gan; 1978 Apr; 69(2):213-21. PubMed ID: 210075
    [Abstract] [Full Text] [Related]

  • 22. Relationship between Epstein-Barr virus-associated nuclear antigen and cell viability in human cell lines.
    Suzuki M, Hinuma Y.
    Gan; 1975 Feb; 66(1):103-5. PubMed ID: 168112
    [Abstract] [Full Text] [Related]

  • 23. [Detection of Epstein-Barr virus in the tonsils in infectious mononucleosis].
    Sauerbrei A, Färber I, Wutzler P, Swoboda R, Schneider J.
    Laryngorhinootologie; 1990 Feb; 69(2):70-3. PubMed ID: 2157451
    [Abstract] [Full Text] [Related]

  • 24. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 25. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
    Rhodes G, Carson DA, Valbracht J, Houghten R, Vaughan JH.
    J Immunol; 1985 Jan; 134(1):211-6. PubMed ID: 2981091
    [Abstract] [Full Text] [Related]

  • 26. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J, Gergely L, Váczi L, Szalka A.
    Acta Microbiol Acad Sci Hung; 1978 Jan; 25(4):237-43. PubMed ID: 224651
    [Abstract] [Full Text] [Related]

  • 27. The effect of tinidazole on primary EBV infection and immunocompetence.
    Marklund G, Ernberg I, Britton S, Lundberg C.
    Scand J Infect Dis; 1984 Jan; 16(1):17-23. PubMed ID: 6320359
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.
    Niedobitek G, Agathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS.
    J Pathol; 1997 Jun; 182(2):151-9. PubMed ID: 9274524
    [Abstract] [Full Text] [Related]

  • 29. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G, Rickinson AB.
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [Abstract] [Full Text] [Related]

  • 30. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 31. Can Epstein-Barr virus infect and transform all the B-lymphocytes of human cord blood?
    Zerbini M, Ernberg I.
    J Gen Virol; 1983 Mar; 64 Pt 3():539-47. PubMed ID: 6298345
    [Abstract] [Full Text] [Related]

  • 32. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
    Seigneurin JM, Kressmann MC, Lavoué MF, Saez G, Lenoir G.
    Nouv Presse Med; 1978 Dec 09; 7(44):4005-10. PubMed ID: 215969
    [Abstract] [Full Text] [Related]

  • 33. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Dec 09; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 34. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
    Joncas JH, Wills A, Reece E, Fox Z.
    Can Med Assoc J; 1981 Oct 15; 125(8):845-9. PubMed ID: 6272957
    [Abstract] [Full Text] [Related]

  • 35. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB.
    J Gen Virol; 1987 Nov 15; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [Abstract] [Full Text] [Related]

  • 36. EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients.
    Klein G, Svedmyr E, Jondal M, Persson PO.
    Int J Cancer; 1976 Jan 15; 17(1):21-6. PubMed ID: 55396
    [Abstract] [Full Text] [Related]

  • 37. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP.
    J Clin Virol; 2011 Sep 15; 52(1):33-7. PubMed ID: 21684200
    [Abstract] [Full Text] [Related]

  • 38. Colonies of EBNA-positive cells in soft agar from peripheral leukocytes of infectious mononucleosis patients.
    Hinuma Y, Katsuki T.
    Int J Cancer; 1978 Apr 15; 21(4):426-31. PubMed ID: 78908
    [Abstract] [Full Text] [Related]

  • 39. The changing faces of EBV research.
    Klein G, Klein E.
    Prog Med Virol; 1984 Apr 15; 30():87-106. PubMed ID: 6087416
    [No Abstract] [Full Text] [Related]

  • 40. Inhibition of Epstein-Barr virus transformation: evidence for a block between EBNA production and cell proliferation.
    Pope JH, Moss DJ.
    IARC Sci Publ (1971); 1978 Apr 15; (24 Pt 2):617-22. PubMed ID: 221385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.